Plant ID: NPO4838
Plant Latin Name: Phlomis umbrosa
Taxonomy Genus: Phlomis
Taxonomy Family: Lamiaceae
NCBI TaxonomyDB:
572134
Plant-of-the-World-Online:
n.a.
Haemostatic; Hepatic
China
GPBAR1; | |
TSHR; | |
PTPN1; PTPN2; CDC25B; | |
PLA2G1B; TDP1; HSD11B1; HSD17B10; AKR1B10; POLB; | |
GAA; | |
PRKCA; | |
CA2; CA1; CA12; CA9; CA7; CA3; CA14; CA5B; CA5A; CA4; CA6; | |
NR1H4; | |
MMP9; MMP1; MMP12; MMP2; | |
HIF1A; NFKB1; | |
SLCO1B3; SLCO1B1; | |
HTT; LMNA; MAPT; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Enzyme_unclassified | PLA2G1B | Phospholipase A2 group 1B | P04054 | CHEMBL4426 |
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | P28845 | CHEMBL4235 |
Enzyme_unclassified | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Enzyme_unclassified | AKR1B10 | Aldo-keto reductase family 1 member B10 | O60218 | CHEMBL5983 |
Enzyme_unclassified | POLB | DNA polymerase beta | P06746 | CHEMBL2392 |
Hydrolase | GAA | Lysosomal alpha-glucosidase | P10253 | CHEMBL2608 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA3 | Carbonic anhydrase III | P07451 | CHEMBL2885 |
Lyase | CA14 | Carbonic anhydrase XIV | Q9ULX7 | CHEMBL3510 |
Lyase | CA5B | Carbonic anhydrase VB | Q9Y2D0 | CHEMBL3969 |
Lyase | CA5A | Carbonic anhydrase VA | P35218 | CHEMBL4789 |
Lyase | CA4 | Carbonic anhydrase IV | P22748 | CHEMBL3729 |
Lyase | CA6 | Carbonic anhydrase VI | P23280 | CHEMBL3025 |
Metallo protease | MMP9 | Matrix metalloproteinase 9 | P14780 | CHEMBL321 |
Metallo protease | MMP1 | Matrix metalloproteinase-1 | P03956 | CHEMBL332 |
Metallo protease | MMP12 | Matrix metalloproteinase 12 | P39900 | CHEMBL4393 |
Metallo protease | MMP2 | Matrix metalloproteinase-2 | P08253 | CHEMBL333 |
Nuclear hormone receptor subfamily 1 group H | NR1H4 | Bile acid receptor FXR | Q96RI1 | CHEMBL2047 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Protein Kinase | PRKCA | Protein kinase C alpha | P17252 | CHEMBL299 |
Protein Phosphatase | PTPN1 | Protein-tyrosine phosphatase 1B | P18031 | CHEMBL335 |
Protein Phosphatase | PTPN2 | T-cell protein-tyrosine phosphatase | P17706 | CHEMBL3807 |
Protein Phosphatase | CDC25B | Dual specificity phosphatase Cdc25B | P30305 | CHEMBL4804 |
SLC superfamily of solute carriers | SLCO1B3 | Solute carrier organic anion transporter family member 1B3 | Q9NPD5 | CHEMBL1743121 |
SLC superfamily of solute carriers | SLCO1B1 | Solute carrier organic anion transporter family member 1B1 | Q9Y6L6 | CHEMBL1697668 |
Small molecule receptor (family A GPCR) | GPBAR1 | G-protein coupled bile acid receptor 1 | Q8TDU6 | CHEMBL5409 |
Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Transcription Factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
Unclassified | HTT | Huntingtin | P42858 | CHEMBL5514 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | Unclassified; | GO:0044236; multicellular organism metabolic process | 4.034E-08 | 5.856E-05 | HIF1A, MMP1, MMP12, MMP2, MMP9, PLA2G1B |
BP | Unclassified; | GO:0044259; multicellular organismal macromolecule metabolic process | 5.260E-07 | 5.454E-04 | HIF1A, MMP1, MMP12, MMP2, MMP9 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 2.339E-28 | 5.094E-24 | CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
CC | GO:0016020; membrane | GO:0016323; basolateral plasma membrane | 1.127E-06 | 1.115E-03 | CA2, CA4, CA9, SLCO1B1, SLCO1B3, TSHR |
BP | GO:0008152; metabolic process | GO:0030574; collagen catabolic process | 6.343E-06 | 5.755E-03 | MMP1, MMP12, MMP2, MMP9 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 1.012E-05 | 7.870E-03 | CA2, CA7 |
BP | GO:0009987; cellular process | GO:0038183; bile acid signaling pathway | 1.012E-05 | 7.870E-03 | GPBAR1, NR1H4 |
MF | GO:0060089; molecular transducer activity | GO:0038181; bile acid receptor activity | 1.012E-05 | 7.870E-03 | GPBAR1, NR1H4 |
BP | GO:0009987; cellular process | GO:0022617; extracellular matrix disassembly | 1.382E-05 | 9.706E-03 | MMP1, MMP12, MMP2, MMP9 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 1.270E-21 | 1.383E-17 | CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 3.148E-20 | 1.371E-16 | CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 1.405E-14 | 3.688E-11 | CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, MMP1, MMP12, MMP2, MMP9, NR1H4, PRKCA, PTPN1 |
MF | GO:0003824; catalytic activity | GO:0004064; arylesterase activity | 5.042E-05 | 2.815E-02 | CA1, CA2 |
MF | GO:0003824; catalytic activity | GO:0004222; metalloendopeptidase activity | 6.062E-05 | 3.143E-02 | MMP1, MMP12, MMP2, MMP9 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09160 Human Diseases | 09161 Cancers | hsa05219 | Bladder cancer | 1.737E-06 | 1.337E-04 | MMP1, MMP2, MMP9 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 9.218E-06 | 3.549E-04 | CA2, SLCO1B3, NR1H4 |
09160 Human Diseases | 09161 Cancers | hsa05200 | Pathways in cancer | 6.672E-05 | 1.284E-03 | MMP1, MMP2, MMP9, NFKB1 |
09160 Human Diseases | 09161 Cancers | hsa05206 | MicroRNAs in cancer | 6.457E-04 | 9.944E-03 | MMP9, NFKB1, CDC25B |
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 4.466E-05 | 1.146E-03 | CA2, CA14 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
I00-I99: Diseases of the circulatory system | Stroke | I61-I63, I80-I82 | MMP9; |
E00-E89: Endocrine, nutritional and metabolic diseases | Obesity | E66 | HSD11B1; |
C00-D49: Neoplasms | Thyroid cancer | C73 | TSHR; |
K00-K95: Diseases of the digestive system | Ulcerative colitis | K51 | MMP9; |
E00-E89: Endocrine, nutritional and metabolic diseases | Hypercholesterolemia | E78 | HSD11B1; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | MMP9; MMP2; |
C00-D49: Neoplasms | Colorectal cancer | C18-C21 | MMP9; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Osteoarthritis | M15-M19, M47 | MMP2; |
C00-D49: Neoplasms | Ovarian cancer | C56 | MMP2; |
K00-K95: Diseases of the digestive system | Duodenal ulcers | K25-K27 | CA2; |
I00-I99: Diseases of the circulatory system | High blood pressure | I10-I16 | CA2; |
NA: NA | Edema | NA | CA2; |
C00-D49: Neoplasms | Non-small-cell lung cancer | NA | MMP2; |
E00-E89: Endocrine, nutritional and metabolic diseases | Non-insulin dependent diabetes | E11.9 | HSD11B1; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Arthritis | M00-M25 | MMP1; |
I00-I99: Diseases of the circulatory system | Atherosclerosis | I70 | HSD11B1; |
W85-W99: Exposure to electric current, radiation and extreme ambient air temperature and pressure | Diagnostic test to differentiate primary and secondary hypothyroidism | W88 | TSHR; |
L00-L99: Diseases of the skin and subcutaneous tissue | Acne vulgaris | L70.0 | MMP2; |
C00-D49: Neoplasms | Pancreatic cancer | C25 | MMP2; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetes | E23.2, N25.1 | HSD11B1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CA2; |
J00-J99: Diseases of the respiratory system | Influenza virus | J11.1 | HSD11B1; |
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | CA2; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetic nephropathy | E11.21 | MMP1; |
C00-D49: Neoplasms | Renal cell carcinoma | NA | MMP2; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | HSD11B1; NFKB1; |
C00-D49: Neoplasms | Thyroid cancer diagnosis | C73 | TSHR; |
E00-E89: Endocrine, nutritional and metabolic diseases | Lipid metabolism disorder | E75-E78 | HSD11B1; |
C00-D49: Neoplasms | Lung cancer | C33-C34 | MMP2; |
H00-H59: Diseases of the eye and adnexa | Ocular hypertension | H40.0 | HSD11B1; |
C00-D49: Neoplasms | Cancer | C00-C96 | NFKB1; MMP9; MMP2; CDC25B; |
I00-I99: Diseases of the circulatory system | Edema associated with congestive heart failure | I50, R60.9 | CA2; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Rheumatoid arthritis | M05-M06 | MMP1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Metabolic syndrome x | E88.81 | HSD11B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Metabolic disorders | E70-E89 | HSD11B1; |